Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy [ADULT BRAIN]
CONCLUSIONS:
The dynamic contrast-enhanced parameter of rate transfer constant from the fixed T1 acted as a preferable marker to differentiate true progression from pseudoprogression.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Nam, J. G., Kang, K. M., Choi, S. H., Lim, W. H., Yoo, R.- E., Kim, J.- H., Yun, T. J., Sohn, C.- H. Tags: ADULT BRAIN Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | Neurology | Radiation Therapy | Study | Temodar